Position in ALKS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,200,800
-$737,100 QoQ
Shares Held
42,000
-60.0% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#169
of 421 holders
Holding Since
Jun 2021
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HUSSMAN STRATEGIC ADVISORS, INC. holds $14,720,685 across 7 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
27,300 | $4,601,142 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
31,500 | $2,607,570 | |
| 3 | ALKS |
Alkermes plc.
This page
|
42,000 | $2,200,800 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
210,000 | $2,100,000 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
42,000 | $1,318,800 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
2,100 | $1,137,843 | |
| 7 | ZTS |
Zoetis Inc.
|
10,500 | $754,530 |
All Filings in ALKS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,200,800 | 42,000 | Shares | Sole | 2026-08-03 | |
| 2025-12-31 | $2,937,900 | 105,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $3,780,000 | 126,000 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $3,604,860 | 126,000 | Shares | Sole | 2025-08-05 | |
| 2024-12-31 | $1,932,672 | 67,200 | Shares | Sole | 2025-02-03 | |
| 2023-06-30 | $388,120 | 12,400 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $436,945 | 15,500 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $405,015 | 15,500 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $346,115 | 15,500 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $461,745 | 15,500 | Shares | Sole | 2022-09-12 | |
| 2022-03-31 | $407,805 | 15,500 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $360,530 | 15,500 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $478,020 | 15,500 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $760,120 | 31,000 | Shares | Sole | 2021-08-03 | |
| No filing history on record for this holder in this stock. | ||||||